#BEGIN_DRUGCARD DB01938

# AHFS_Codes:
Not Available

# ATC_Codes:
Not Available

# Absorption:
Not Available

# Biotransformation:
Not Available

# Brand_Mixtures:
Not Available

# Brand_Names:
Not Available

# CAS_Registry_Number:
Not Available

# ChEBI_ID:
Not Available

# Chemical_Formula:
C16H16N4O

# Chemical_IUPAC_Name:
(2R)-2-amino-3-(1H-imidazol-5-yl)-N-(naphthalen-2-yl)propanamide

# Chemical_Structure:
Not Available

# Creation_Date:
2005-06-13 07:24:05 -0600

# DPD_Drug_ID_Number:
Not Available

# Description:
Not Available

# Dosage_Forms:
Not Available

# Drug_Category:
Not Available

# Drug_Interactions:
Not Available

# Drug_Reference:
Not Available

# Drug_Type:
Experimental
Small Molecule

# Experimental_Caco2_Permeability:
Not Available

# Experimental_LogP_Hydrophobicity:
Not Available

# Experimental_Logs:
Not Available

# Experimental_Water_Solubility:
Not Available

# Food_Interactions:
Not Available

# GenBank_ID:
Not Available

# Generic_Name:
L-Histidine Beta Naphthylamide

# HET_ID:
HBN

# Half_Life:
Not Available

# InChI_Identifier:
InChI=1S/C16H16N4O/c17-15(8-14-9-18-10-19-14)16(21)20-13-6-5-11-3-1-2-4-12(11)7-13/h1-7,9-10,15H,8,17H2,(H,18,19)(H,20,21)/t15-/m1/s1

# InChI_Key:
InChIKey=DKDILZBBFKZMRO-OAHLLOKOSA-N

# Indication:
Not Available

# KEGG_Compound_ID:
Not Available

# KEGG_Drug_ID:
Not Available

# LIMS_Drug_ID:
1938

# Mechanism_Of_Action:
Not Available

# Melting_Point:
Not Available

# Molecular_Weight_Avg:
280.3244

# Molecular_Weight_Mono:
280.132411154

# Organisms_Affected:
Not Available

# PDB_Experimental_ID:
1VEA

# PDB_Homology_ID:
Not Available

# PDRhealth_Link:
Not Available

# Pathways:
Not Available

# PharmGKB_ID:
Not Available

# Pharmacology:
Not Available

# Predicted_LogP_Hydrophobicity:
1.1

# Predicted_LogS:
-3.4

# Predicted_Water_Solubility:
1.04e-01 g/l

# Primary_Accession_No:
DB01938

# Protein_Binding:
Not Available

# PubChem_Compound_ID:
6541406

# PubChem_Substance_ID:
46505793

# RxList_Link:
Not Available

# Salts:
Not Available

# Secondary_Accession_No:
EXPT01699

# Smiles_String_canonical:
Not Available

# Smiles_String_isomeric:
[H][C@@](N)(CC1=CN=CN1)C(=O)NC1=CC=C2C=CC=CC2=C1

# State:
solid

# Structure:
1

# SwissProt_ID:
Not Available

# SwissProt_Name:
Not Available

# Synonyms:
Not Available

# Synthesis_Reference:
Not Available

# Toxicity:
Not Available

# Update_Date:
2013-02-08 16:20:38 -0700

# Wikipedia_Link:
Not Available

# pKa_Isoelectric_Point:
Not Available

# Drug_Target_1_Cellular_Location:
Not Available

# Drug_Target_1_Chromosome_Location:
Not Available

# Drug_Target_1_Drug_References:
10592235	Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42.
17016423	Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.
17139284	Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.

# Drug_Target_1_Essentiality:
Non-Essential

# Drug_Target_1_GenAtlas_ID:
Not Available

# Drug_Target_1_GenBank_ID_Gene:
M20659

# Drug_Target_1_GenBank_ID_Protein:
143075

# Drug_Target_1_GeneCard_ID:
Not Available

# Drug_Target_1_Gene_Name:
hutP

# Drug_Target_1_Gene_Sequence:
>456 bp
GTGATTCATATGACACTGCATAAAGAGCGTCGGATCGGCCGGCTGTCTGTTCTCCTGCTG
CTGAATGAGGCGGAAGAAAGTACGCAGGTTGAGGAGCTGGAGCGAGACGGATGGAAGGTC
TGTCTTGGCAAGGTAGGATCAATGGACGCACATAAAGTAGTAGCCGCAATTGAAACCGCT
TCCAAAAAGAGCGGTGTCATTCAATCTGAGGGTTATCGGGAGTCACATGCGCTTTATCAT
GCGACGATGGAGGCTTTGCATGGCGTGACCAGAGGTGAAATGCTGCTGGGATCGCTGCTT
CGGACGGTGGGATTGAGGTTTGCCGTTTTGAGGGGAAATCCTTATGAAAGTGAAGCGGAA
GGCGATTGGATCGCTGTCTCGCTTTACGGAACAATCGGGGCGCCGATTAAAGGTCTTGAG
CATGAAACATTCGGCGTTGGAATTAATCACATATGA

# Drug_Target_1_General_Function:
Involved in mRNA binding

# Drug_Target_1_General_References:
10712704	Oda M, Kobayashi N, Ito A, Kurusu Y, Taira K: cis-acting regulatory sequences for antitermination in the transcript of the Bacillus subtilis hut operon and histidine-dependent binding of HutP to the transcript containing the regulatory sequences. Mol Microbiol. 2000 Mar;35(5):1244-54.
12217662	Kumarevel TS, Fujimoto Z, Padmanabhan B, Oda M, Nishikawa S, Mizuno H, Kumar PK: Crystallization and preliminary X-ray diffraction studies of HutP protein: an RNA-binding protein that regulates the transcription of hut operon in Bacillus subtilis. J Struct Biol. 2002 Jun;138(3):237-40.
2454913	Oda M, Sugishita A, Furukawa K: Cloning and nucleotide sequences of histidase and regulatory genes in the Bacillus subtilis hut operon and positive regulation of the operon. J Bacteriol. 1988 Jul;170(7):3199-205.
7704263	Yoshida K, Sano H, Seki S, Oda M, Fujimura M, Fujita Y: Cloning and sequencing of a 29 kb region of the Bacillus subtilis genome containing the hut and wapA loci. Microbiology. 1995 Feb;141 ( Pt 2):337-43.
9384377	Kunst F, Ogasawara N, Moszer I, Albertini AM, Alloni G, Azevedo V, Bertero MG, Bessieres P, Bolotin A, Borchert S, Borriss R, Boursier L, Brans A, Braun M, Brignell SC, Bron S, Brouillet S, Bruschi CV, Caldwell B, Capuano V, Carter NM, Choi SK, Codani JJ, Connerton IF, Danchin A, et al.: The complete genome sequence of the gram-positive bacterium Bacillus subtilis. Nature. 1997 Nov 20;390(6657):249-56.

# Drug_Target_1_HGNC_ID:
Not Available

# Drug_Target_1_HPRD_ID:
Not Available

# Drug_Target_1_ID:
2351

# Drug_Target_1_Locus:
Not Available

# Drug_Target_1_Molecular_Weight:
16196

# Drug_Target_1_Name:
Hut operon positive regulatory protein

# Drug_Target_1_Number_of_Residues:
148

# Drug_Target_1_PDB_ID:
1VEA

# Drug_Target_1_Pathway:
Not Available

# Drug_Target_1_Pfam_Domain_Function:
Not Available

# Drug_Target_1_Protein_Sequence:
>Hut operon positive regulatory protein
MTLHKERRIGRLSVLLLLNEAEESTQVEELERDGWKVCLGKVGSMDAHKVVAAIETASKK
SGVIQSEGYRESHALYHATMEALHGVTRGEMLLGSLLRTVGLRFAVLRGNPYESEAEGDW
IAVSLYGTIGAPIKGLEHETFGVGINHI

# Drug_Target_1_Reaction:
Not Available

# Drug_Target_1_Signals:
None

# Drug_Target_1_Specific_Function:
Antiterminator that binds to cis-acting regulatory sequences on the mRNA in the presence of histidine, thereby suppressing transcription termination and activating the hut operon for histidine utilization

# Drug_Target_1_SwissProt_ID:
P10943

# Drug_Target_1_SwissProt_Name:
HUTP_BACSU

# Drug_Target_1_Synonyms:
Not Available

# Drug_Target_1_Theoretical_pI:
6.40

# Drug_Target_1_Transmembrane_Regions:
None

#END_DRUGCARD DB01938
